National survey of clinical pharmacology (CP) education in medical schools and internal medicine residency programs

C. J. Rosebraugh, S. U. Yasuda, J. C. Pezzullo, P. K. Honig, D. A. Flockhart, R. L. Woosley

Research output: Contribution to journalArticle

Abstract

Purpose: Survey nationally curriculum and physician trainee exposure to CP. Methods: Surveys were developed and sent to each Internal Medicine Clerkship and Residency Program Director in the United States. Results: 86% of responding clerkships (n=53) and 39% of residencies (n= 104) reported no training (see graph). 12% of medical schools have mandatory, and 56% have elective, CP during clinical training. Based on a l(y)-5(n) Likert scale, the majority of programs would incorporate educational programs (clerkespecially those regarding adverse drug reactions. (Figure Presented) Conclusion: Nationally, future physicians have limited exposure to CP. Clinical educators recognize this as a weakness in their programs and would increase future physician CP training if educational modules or expertise were available.

Original languageEnglish (US)
JournalClinical Pharmacology and Therapeutics
Volume69
Issue number2
StatePublished - 2001
Externally publishedYes

Fingerprint

Clinical Pharmacology
Internship and Residency
Internal Medicine
Medical Schools
Education
Physicians
Drug-Related Side Effects and Adverse Reactions
Curriculum
Surveys and Questionnaires

ASJC Scopus subject areas

  • Pharmacology

Cite this

Rosebraugh, C. J., Yasuda, S. U., Pezzullo, J. C., Honig, P. K., Flockhart, D. A., & Woosley, R. L. (2001). National survey of clinical pharmacology (CP) education in medical schools and internal medicine residency programs. Clinical Pharmacology and Therapeutics, 69(2).

National survey of clinical pharmacology (CP) education in medical schools and internal medicine residency programs. / Rosebraugh, C. J.; Yasuda, S. U.; Pezzullo, J. C.; Honig, P. K.; Flockhart, D. A.; Woosley, R. L.

In: Clinical Pharmacology and Therapeutics, Vol. 69, No. 2, 2001.

Research output: Contribution to journalArticle

Rosebraugh, CJ, Yasuda, SU, Pezzullo, JC, Honig, PK, Flockhart, DA & Woosley, RL 2001, 'National survey of clinical pharmacology (CP) education in medical schools and internal medicine residency programs', Clinical Pharmacology and Therapeutics, vol. 69, no. 2.
Rosebraugh, C. J. ; Yasuda, S. U. ; Pezzullo, J. C. ; Honig, P. K. ; Flockhart, D. A. ; Woosley, R. L. / National survey of clinical pharmacology (CP) education in medical schools and internal medicine residency programs. In: Clinical Pharmacology and Therapeutics. 2001 ; Vol. 69, No. 2.
@article{db4ff1e37151412f999c54e1255fb27f,
title = "National survey of clinical pharmacology (CP) education in medical schools and internal medicine residency programs",
abstract = "Purpose: Survey nationally curriculum and physician trainee exposure to CP. Methods: Surveys were developed and sent to each Internal Medicine Clerkship and Residency Program Director in the United States. Results: 86{\%} of responding clerkships (n=53) and 39{\%} of residencies (n= 104) reported no training (see graph). 12{\%} of medical schools have mandatory, and 56{\%} have elective, CP during clinical training. Based on a l(y)-5(n) Likert scale, the majority of programs would incorporate educational programs (clerkespecially those regarding adverse drug reactions. (Figure Presented) Conclusion: Nationally, future physicians have limited exposure to CP. Clinical educators recognize this as a weakness in their programs and would increase future physician CP training if educational modules or expertise were available.",
author = "Rosebraugh, {C. J.} and Yasuda, {S. U.} and Pezzullo, {J. C.} and Honig, {P. K.} and Flockhart, {D. A.} and Woosley, {R. L.}",
year = "2001",
language = "English (US)",
volume = "69",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - National survey of clinical pharmacology (CP) education in medical schools and internal medicine residency programs

AU - Rosebraugh, C. J.

AU - Yasuda, S. U.

AU - Pezzullo, J. C.

AU - Honig, P. K.

AU - Flockhart, D. A.

AU - Woosley, R. L.

PY - 2001

Y1 - 2001

N2 - Purpose: Survey nationally curriculum and physician trainee exposure to CP. Methods: Surveys were developed and sent to each Internal Medicine Clerkship and Residency Program Director in the United States. Results: 86% of responding clerkships (n=53) and 39% of residencies (n= 104) reported no training (see graph). 12% of medical schools have mandatory, and 56% have elective, CP during clinical training. Based on a l(y)-5(n) Likert scale, the majority of programs would incorporate educational programs (clerkespecially those regarding adverse drug reactions. (Figure Presented) Conclusion: Nationally, future physicians have limited exposure to CP. Clinical educators recognize this as a weakness in their programs and would increase future physician CP training if educational modules or expertise were available.

AB - Purpose: Survey nationally curriculum and physician trainee exposure to CP. Methods: Surveys were developed and sent to each Internal Medicine Clerkship and Residency Program Director in the United States. Results: 86% of responding clerkships (n=53) and 39% of residencies (n= 104) reported no training (see graph). 12% of medical schools have mandatory, and 56% have elective, CP during clinical training. Based on a l(y)-5(n) Likert scale, the majority of programs would incorporate educational programs (clerkespecially those regarding adverse drug reactions. (Figure Presented) Conclusion: Nationally, future physicians have limited exposure to CP. Clinical educators recognize this as a weakness in their programs and would increase future physician CP training if educational modules or expertise were available.

UR - http://www.scopus.com/inward/record.url?scp=33748983354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748983354&partnerID=8YFLogxK

M3 - Article

VL - 69

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 2

ER -